Literature DB >> 1409361

Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production.

R Gaspar1, V Préat, F R Opperdoes, M Roland.   

Abstract

Nanoparticles of polyalkylcyanoacrylates (PACA) can be useful carrier for the targeting of antileishmanial drugs into macrophages and also possess significant antileishmanial activity by themselves. No significant difference in antileishmanial activity could be detected between nanoparticles of five PACAs with differing alkyl side chains, suggesting that the main degradation products of PACA are not involved in their antileishmanial action. The effect of polyisohexylcyanoacrylate (PIHCA) on the induction of the respiratory burst in a macrophage-like cell line (J774G8) was assessed in non-infected macrophages and in macrophages infected with amastigotes of Leishmania donovani infantum, by measuring nitroblue tetrazolium (NBT) reduction and hydrogen peroxide production. Phagocytosis of PIHCA nanoparticles led to a respiratory burst, which was more pronounced in infected than in uninfected macrophages. The production of reactive oxygen intermediates associated with the respiratory burst was inhibited by addition of superoxide dismutase and catalase to the cell suspensions. The addition of catalase to the culture medium together with PIHCA nanoparticles significantly reduced the antileishmanial activity of PIHCA. Moreover PIHCA nanoparticles did not induce interleukin-1 release by macrophages. It is suggested that the antileishmanial action of PIHCA and other PACA nanoparticles results from the activation of respiratory burst in macrophages.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409361     DOI: 10.1023/a:1015807706530

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader.

Authors:  E Pick
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

2.  Interleukin 1 from human leukemic monocytes.

Authors:  L B Lachman; L C Shih; D C Brown
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

3.  Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.

Authors:  H W Murray
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

4.  Degradation of poly (isobutyl cyanoacrylate) nanoparticles.

Authors:  V Lenaerts; P Couvreur; D Christiaens-Leyh; E Joiris; M Roland; B Rollman; P Speiser
Journal:  Biomaterials       Date:  1984-03       Impact factor: 12.479

5.  Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes.

Authors:  R D Pearson; R T Steigbigel
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

Review 6.  Polyalkylcyanoacrylates as colloidal drug carriers.

Authors:  P Couvreur
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

7.  Macrophage stimulation with some structurally related polysaccharides.

Authors:  P Artursson; P Edman; J L Ericsson
Journal:  Scand J Immunol       Date:  1987-03       Impact factor: 3.487

8.  Biodegradable microspheres. V: Stimulation of macrophages with microparticles made of various polysaccharides.

Authors:  P Artursson; E Arro; P Edman; J L Ericsson; I Sjöholm
Journal:  J Pharm Sci       Date:  1987-02       Impact factor: 3.534

9.  Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages.

Authors:  H W Murray
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates.

Authors:  H W Murray
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

2.  Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells.

Authors:  H Suh; B Jeong; F Liu; S W Kim
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

3.  Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production.

Authors:  T Cruz; R Gaspar; A Donato; C Lopes
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

4.  Microcalorimetric method to assess phagocytosis: macrophage-nanoparticle interactions.

Authors:  M H D Kamal Al-Hallak; Muhammad Khan Sarfraz; Shirzad Azarmi; M H Gilzad Kohan; Wilson H Roa; Raimar Löbenberg
Journal:  AAPS J       Date:  2010-11-06       Impact factor: 4.009

5.  Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation.

Authors:  Wei Huang; Chenming Zhang
Journal:  Biotechnol J       Date:  2017-10-13       Impact factor: 4.677

Review 6.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

7.  Long-term prevalence of NIRF-labeled magnetic nanoparticles for the diagnostic and intraoperative imaging of inflammation.

Authors:  Jenny Domey; Christian Bergemann; Sibylle Bremer-Streck; Ines Krumbein; Jürgen R Reichenbach; Ulf Teichgräber; Ingrid Hilger
Journal:  Nanotoxicology       Date:  2015-02-17       Impact factor: 5.913

8.  Nanotechnology-based drug delivery systems.

Authors:  Sarabjeet Singh Suri; Hicham Fenniri; Baljit Singh
Journal:  J Occup Med Toxicol       Date:  2007-12-01       Impact factor: 2.646

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.